What is Janux Therapeutics, Inc. Common Stock's Market Cap?

Janux Therapeutics, Inc. Common Stock's Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's Enterprise Value?

Janux Therapeutics, Inc. Common Stock's Enterprise Value is $254.3M, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's Price / Sales?

Janux Therapeutics, Inc. Common Stock's Price / Sales is 51.0×, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's EV / Revenue?

Janux Therapeutics, Inc. Common Stock's EV / Revenue is 10.6×, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's EV / EBITDA?

Janux Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's Revenue (TTM)?

Janux Therapeutics, Inc. Common Stock's Revenue (TTM) is $24.0M, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's Net Income (TTM)?

Janux Therapeutics, Inc. Common Stock's Net Income (TTM) is -$102.6M, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's EBITDA?

Janux Therapeutics, Inc. Common Stock's EBITDA is -$141.7M, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Janux Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.68, based on as-reported figures from SEC (XBRL) filings.

What is Janux Therapeutics, Inc. Common Stock's EBITDA Margin?

Janux Therapeutics, Inc. Common Stock's EBITDA Margin is -590.2%, based on as-reported figures from SEC (XBRL) filings.

Janux Therapeutics, Inc. Common Stock (JANX) Financial Statements

Janux Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZHSKH39

XNAS · usd

20.04▼ 0.20 (-0.99%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close20.24

Day's Range19.67 – 20.25

52-Week Range12.11 – 35.34

Volume1.1M

Avg Volume764.1K

Share Statistics

Shares Outstanding

Employees109

ExchangeXNAS

Listed2021-06-11

Share count as of August 4, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Janux Therapeutics, Inc. Common Stock (JANX)

What is Janux Therapeutics, Inc. Common Stock's Market Cap?: Janux Therapeutics, Inc. Common Stock's Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's Enterprise Value?: Janux Therapeutics, Inc. Common Stock's Enterprise Value is $254.3M, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's Price / Sales?: Janux Therapeutics, Inc. Common Stock's Price / Sales is 51.0×, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's EV / Revenue?: Janux Therapeutics, Inc. Common Stock's EV / Revenue is 10.6×, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's EV / EBITDA?: Janux Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's Revenue (TTM)?: Janux Therapeutics, Inc. Common Stock's Revenue (TTM) is $24.0M, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's Net Income (TTM)?: Janux Therapeutics, Inc. Common Stock's Net Income (TTM) is -$102.6M, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's EBITDA?: Janux Therapeutics, Inc. Common Stock's EBITDA is -$141.7M, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Janux Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.68, based on as-reported figures from SEC (XBRL) filings.
What is Janux Therapeutics, Inc. Common Stock's EBITDA Margin?: Janux Therapeutics, Inc. Common Stock's EBITDA Margin is -590.2%, based on as-reported figures from SEC (XBRL) filings.